Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.

Chu J, Giannopoulos PF, Ceballos-Diaz C, Golde TE, Praticò D.

Ann Neurol. 2012 Sep;72(3):442-54. doi: 10.1002/ana.23642.

2.

Novel lipid signaling pathways in Alzheimer's disease pathogenesis.

Giannopoulos PF, Joshi YB, Praticò D.

Biochem Pharmacol. 2014 Apr 15;88(4):560-4. doi: 10.1016/j.bcp.2013.11.005. Epub 2013 Nov 21. Review.

3.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
4.
5.

The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target.

Chu J, Praticò D.

Brain Res Bull. 2016 Sep;126(Pt 2):207-212. doi: 10.1016/j.brainresbull.2016.03.010. Epub 2016 Mar 19. Review.

6.

Transgenic mouse models of Alzheimer's disease.

Janus C, Chishti MA, Westaway D.

Biochim Biophys Acta. 2000 Jul 26;1502(1):63-75. Review. No abstract available.

7.

The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease.

Joshi YB, Giannopoulos PF, Praticò D.

Trends Pharmacol Sci. 2015 Mar;36(3):181-186. doi: 10.1016/j.tips.2015.01.005. Epub 2015 Feb 20. Review.

8.

Alzheimer's Disease and ncRNAs.

Maoz R, Garfinkel BP, Soreq H.

Adv Exp Med Biol. 2017;978:337-361. doi: 10.1007/978-3-319-53889-1_18. Review.

PMID:
28523555
9.

The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype.

Joshi YB, Praticò D.

Front Cell Neurosci. 2015 Jan 14;8:436. doi: 10.3389/fncel.2014.00436. eCollection 2014. Review.

Supplemental Content

Support Center